What is Corcept Therapeutics's gross profit?

Corcept Therapeutics (CORT) reported gross profit of $162.02M in Q1 2026.

How has Corcept Therapeutics's gross profit changed year-over-year?

Corcept Therapeutics's gross profit increased by 4.7% year-over-year, from $154.81M to $162.02M.

What is the long-term trend for Corcept Therapeutics's gross profit?

Over 4 years (2021 to 2025), Corcept Therapeutics's gross profit has grown at a 20.0% compound annual growth rate (CAGR), from $360.7M to $748.43M.

Corcept Therapeutics CORT Gross Profit

Discontinued — last reported Q1 '26

Gross Profit at other companies

Eli LillyLLY

$16.22B+54.4%

Gilead SciencesGILD

$5.52B+7.6%

ExelixisEXEL

——

IncyteINCY

——

ImmunityBio, Inc.IBRX

——

Madrigal Pharmaceuticals, Inc.MDGL

——

Other financials

Income statement

See full

Revenue$164.9M+4.9%

Operating income-$49.6M-1,552%

Net income-$31.8M-255%

EPS (diluted)-$0.30-276%

Balance sheet

See full

Cash & equivalents$110.0M+21.1%

Total debt$9.6M+41.0%

Total equity$638.0M-6.6%

Total assets$814.9M-3.7%

Cash flow

See full

Operating cash flow-$16.8M-452%

CapEx$201.0K+93.3%

Free cash flow-$17.0M-464%

Valuation

See full

Market cap$8.58B-64.4%

Enterprise value$8.48B-65.0%

P/E181.2×+1.3×

P/S11.2×-24.0×

Profitability

See full

Gross margin98.3%-0.2pp

Operating margin-1.1%-17.2pp

Net margin6.2%-13.4pp

FCF margin15.6%-10.2pp

Returns & leverage

See full

Return on equity7.2%-14.6pp

Debt / equity0×0.0×

Current ratio2.9×-0.2×

Where this comes from

Calculated from Corcept Therapeutics’s reported figures.

$164.9Mtotal revenue−$2.9Mtotal cost of revenue=$162.02M

The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corcept Therapeutics's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Corcept Therapeutics's gross profit?: Corcept Therapeutics (CORT) reported gross profit of $162.02M in Q1 2026.
How has Corcept Therapeutics's gross profit changed year-over-year?: Corcept Therapeutics's gross profit increased by 4.7% year-over-year, from $154.81M to $162.02M.
What is the long-term trend for Corcept Therapeutics's gross profit?: Over 4 years (2021 to 2025), Corcept Therapeutics's gross profit has grown at a 20.0% compound annual growth rate (CAGR), from $360.7M to $748.43M.